(Q33673678)

28 July 2017

1 reference

title

Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases (English)

1 reference

28 July 2017

main subject

cardiovascular disease

1 reference

Eto T

1

1 reference

28 July 2017

Kitamura K

series ordinal

2

1 reference

28 July 2017

Kato J

series ordinal

3

1 reference

28 July 2017

publication date

1 May 1999

1 reference

Clinical and Experimental Pharmacology and Physiology

28 July 2017

published in

1 reference

28 July 2017

volume

26

1 reference

28 July 2017

issue

5-6

1 reference

28 July 2017

page(s)

371-380

1 reference

Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Cloning and characterization of cDNA encoding a precursor for human adrenomedullin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Genomic structure of human adrenomedullin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

The relaxant effect of adrenomedullin on particular smooth muscles despite a general expression of its mRNA in smooth muscle, endothelial and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Expression of adrenomedullin and its receptor during embryogenesis suggests autocrine or paracrine modes of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Receptors for adrenomedullin in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Attenuation of adrenomedullin‐induced renal vasodilatation by NG‐nitro L‐arginine but not glibenclamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Adrenomedullin, a newly discovered hypotensive peptide, is a potent bronchodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Hypothalamic Integration: Organization of the Paraventricular and Supraoptic Nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Different secretion patterns of adrenomedullin, brain natriuretic peptide, and atrial natriuretic peptide during exercise in hypertensive and normotensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Plasma adrenomedullin concentration in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Cardiac secretion of adrenomedullin in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Plasma adrenomedullin in patients with primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Haemodynamic responses to rat adrenomedullin in anaesthetized spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.1999.03047.X

10.1046/J.1440-1681.1999.03047.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference